31/08/2015 21:55:46 Free Membership Login

   

Acorda Therapeutics Inc

Visual Financials
Company Name: Acorda Therapeutics Inc
Ticker Symbol: ACOR
CIK Number: 0001008848
WWW Address: http://www.acorda.com
CEO: Ron Cohen,M.D.
No. of Employees: 489
Common Issue Type: CS
Business Description:Acorda Therapeutics, Inc. is engaged in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and disorders of the central nervous system.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 31.94 Down -0.79 31.8 32.09  33.39 31.53 901184
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,368.5 42.8 0.00 0.43 0.00 73.5 0.0 45.45 - 27.12
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close31.97$
PE Ratio - LTM73.5
Market Capitalisation1,368.5mil
Latest Shares Outstanding42.8mil
Earnings pS (EPS)0.43$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee821,022$
Effective Tax Rate0.4%
Float31.1mil
Float as % of Shares Outstanding0.7%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.50%
Research & Devlopment (R&D) as % of Revenue0.20%
Gross Profit Margin79.9%
EBITDA Margin11.4%
Pre-Tax Profit Margin0.0%
Assets Turnover47.6%
Return on Assets (ROA)2.1%
Return on Equity (ROE)3.6%
Return on Capital Invested (ROCI)3.6%
Current Ratio3.6
Leverage Ratio (Assets/Equity)2.0
Interest Cover4.0
Total Debt/Equity (Gearing Ratio)0.54
LT Debt/Total Capital35.0%
Working Capital pS6.88$
Cash pS0.00$
Book-Value pS13.08$
Tangible Book-Value pS-1.76$
Cash Flow pS1.09$
Free Cash Flow pS0.86$
KEY FIGURES (LTM): Price info
Price/Book Ratio2.50
Price/Tangible Book Ratio0.00
Price/Cash Flow30.2
Price/Free Cash Flow38.3
P/E as % of Industry Group35.0%
P/E as % of Sector Segment7.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---13.091,220,145838,415
4 Weeks35.1927.1234.72-5.7754,35315,841,413
13 Weeks36.2827.1230.387.714584,85038,015,261
26 Weeks36.8327.1235.00-6.5578,45174,620,193
52 Weeks45.4527.1232.171.73631,542160,411,847
YTD45.4527.12--19.2-15630,171106,498,977
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
31.9330.9433.2033.5235.120.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.490.70.11
Income0.0-0.17
Dividend0.0
Capital Spending0.14NA0.04
R&D13.69NA18.15
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %0.90.94.6
Earnings %-100.0-100.0406.3
EPS %-100.0-100.0405.3
EPS $-0.22-0.223.08
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio27.27
Current Ratio3.6
Quick Ratio (Acid Test)3.0
Liquidity Ratio (Cash)4.29
Receivables Turnover12.7
Average Collection Period28
Working Capital/Equity54.6
Working Capital pS6.92
Cash-Flow pS1.76
Free Cash-Flow pS1.58
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio2.42
Financial Leverage Ratio (Assets/Equity)0.5
Debt Ratio26.9
Total Debt/Equity (Gearing Ratio)0.54
LT Debt/Equity0.54
LT Debt/Capital Invested51.3
LT Debt/Total Liabilities99.6
Interest Cover4.0
Interest/Capital Invested0.96
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.30
Current P/E Ratio - LTM73.50
Enterprise Value (EV)/EBITDA31.72
Enterprise Value (EV)/Free Cash Flow19.53
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM2.50
Price/Cash Flow Ratio30.2
Price/Free Cash Flow Ratio - LTM38.3
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM9.6
P/E Ratio (26 weeks ago) - LTM29.6
P/E Ratio (52 weeks ago) - LTM24.7
5-Y High P/E Ratio189.1
5-Y Low P/E Ratio76.4
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E3
P/E as % of Industry Group35.0
P/E as % of Sector Segment7.0
Current 12 Month Normalized P/E Ratio - LTM9.4
PER SHARE FIGURES
LT Debt pS8.14
Current Liabilities pS3.21
Tangible Book Value pS - LTM-1.76
Book Value pS - LTM13.08
Capital Invested pS19.40
Cash pS - LTM0.00
Cash Flow pS - LTM1.09
Free Cash Flow pS - LTM0.86
Earnings pS (EPS)0.43
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin16.75
Free Cash Flow Margin 5YEAR AVG8.92
Net Profit Margin0.1
Net Profit Margin - 5YEAR AVRG.0.1
Equity Productivity0.74
Return on Equity (ROE)0.0
Return on Equity (ROE) - 5YEAR AVRG.0.1
Capital Invested Productivity0.48
Return on Capital Invested (ROCI)0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.1
Assets Productivity0.50
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.0.1
Gross Profit Margin79.9
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM11.4
EBIT Margin - LTM9.3
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.
Effective Tax Rate15.7
Effective Tax Rate - 5YEAR AVRG.-101.9
EFFICIENCY RATIOS
Cash Conversion Cycle1,124,862
Revenue per Employee821,022
Net Income per Employee36,139
Average Collection Period1,124,862
Receivables Turnover12.7
Day's Inventory Turnover Ratio
Inventory Turnover3.0
Inventory/Sales6.7
Accounts Payble/Sales4.71
Assets/Revenue2.00
Net Working Capital Turnover1.36
Fixed Assets Turnover0.60
Total Assets Turnover0.5
Revenue per $ Cash2.20
Revenue per $ Plant8.71
Revenue per $ Common Equity0.74
Revenue per $ Capital Invested0.48
Selling, General & Adm/tive (SG&A) as % of Revenue50.3
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue18.3
R&D Expense as % of Revenue - 5YEAR AVRG.18.3

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq acor150831 21:55